Prostaglandins E, and F, o were administered by mouth to induce labour in 24 patients at or past term. The drugs were administered at two-hourly intervals in doses ranging from 0-5 to 15 mg for prostaglandin E, and from 5 to 15 mg for prostaglandin F,x. Of the 10 cases in which prostaglandin E. was used, labour was successfully induced in eight and there were no side effects. With prostaglandin F,or labour was induced in 12 of 14 patients nine of whom had gastrointestinal disturbance, mostly of mild degree. With both drugs the infant was apparently unaffected and Apgar scores were satisfactory. Uterine hypertonus was not observed and the postpartum blood loss was within normal limits.
Thus in the context of advanced neoplastic disease immunotherapy carried out by the method described provides a form of palliation for some patients. It does not offer a cure in these patients. Whether this method would improve the survival rate by killing all tumour cells in patients with only a small residual tumour load after surgery remains to be decided. Other aspects require investigation. 'What are the mechanisms of the tumour rejection observed? Is there an increase in the number of cytotoxic lymphocytes, is blocking factor (Hellstrom and Hellstrom, 1970a) reduced, are unblocking factors (Hellstrom and Hellstr6m, 1970b; Bansal and Sjogren, 1971 ) produced? With a greater understanding of the mechanisms involved it might prove possible to design a more effective immunotherapeutic regimen by altering the constitution, frequency, and number of doses of vaccine. It might also prove possible to determine which patients are likely to derive most benefit from immunotherapy. It is, however, very unlikely that immunotherapy will ever replace other, conventional forms of therapy but it could become a useful adjunct to surgery, radiotherapy, and chemotherapy.
We wish to thank colleagues for referring patients for immunotherapy, particularly Mr. H. B. Torrance and Mr. T. B. Fitzgerald. We would also like to thank the research grants committee of the United Manchester Hospitals for supporting this project.
Introduction
Recent clinical trials with prostaglandins E, and F., have established their efficacy in inducing labour when administered by continuous intravenous infusion (Karim et al., 1968 Beazley et al., 1970; Embrey, 1970; Karim, 1970 .) It (Karim, 1971; Karim and Sharma, 1971 ) that these drugs are effective when given by mouth, but the available evidence is scanty and there is as yet no published work on the subject from the Western hemisphere. The present study is of a preliminary trial of the action of both these prostaglandins in the induction of labour when administered by the oral route and reports the results obtained in 24 patients who were studied in detail.
Patients and Materials Twenty-four patients were included in the series, of whom 10
were treated with prostaglandin E2 and 14 with F,ax. All were at or past term, and the reasons for induction are listed in Table   II (E,) and Table III (F,ac). Ages ranged from 21 to 37 years, and all, with the exception of one primigravida, were healthy parous patients whose membranes were intact at the onset of treatment. In all cases the "inducibility" rating of the patient was assessed by the method of Bishop (1964) (see Table I ) and Case 10 was the only primigravida in the series. Amniotomy with subsequent intravenous Syntocinon infusion had originally been intended and the former was attempted, but proved to be impossible on account of a high tightly-closed cervix and a high free-presenting head. With 0-5-mg aliquots of prostaglandin E, regular contractions were induced, but any increase above this dosage produced excessive and irregular uterine activity with transient bradycardia. This is illustrated in Fig. 2 
RESULTS
The results obtained in the 10 cases investigated are shown in Table II . It will be seen that in Cases 1 to 8 orderly uterine activity was readily established and resulted in normal delivery. it would seem that the contraction baseline does not return to the normal resting level betwen contractions, this is an artefact associated with the method of external tocography which was used; there was no evidence of uterine hypertonus. After five doses (5 mg) of prostaglandin E, the cervix had dilated sufficiently to allow amniotomy, and thereafter intravenous Syntocinon infusion was begun. However,within eighL minutes there was recurrence of excessive uterine activity similar to that seen with the increased dosage of E, and this was coincident with fetal bradycardia, the heart rate dropping to 80 beats per minute (see Fig. 3 Fetal.-As shown in Table II the Apgar scores at five minutes were all in the satisfactory range. Routine recording of the fetal heart rate throughout labour showed no significant variation except for that described in Case 10.
Prostaglandin F2x PREPARATION AND DOSAGE
Initially it was attempted to administer prostaglandin Fax in the same manner as prostaglandin E ,-namely, in the form of a draught of water containing the drug-but in the first three patients this produced rapid onset of vomiting and diarrhoea of such severity that the drug had to be discontinued and alternative methods of induction used. These cases have not been included in the series.
Thereafter the drug was administered in capsule form, each capsule containing 5 mg of prostaglandin F2a. A test dose of 5 mg was followed in half an hour by a further dose of 10 mg, and, dependent on uterine response, subsequent doses of 15 mg were administered every two hours until, as with E2, labour was established and amniotomy was undertaken.
RESULTS
Fourteen patients were treated and the results are shown in Table III . In 12 cases labour was readily established and in all but one resulted in normal delivery, the time from induction to delivery ranging from 3 hours 45 minutes to 14 hours 53 minutes, with a mean of 11 hours 18 minutes. Fig. 4 shows sample recordings of the uterine contractions from Case 12. The exception was Case 13, who responded well to the drug and in 10hours 30 minutes had reached full dilatation of the cervix, but fetal bradycardia then developed and the head had failed to engage. Caesarean section produced a healthy male child weighing no less than 4-36 kg. In Case 19 prostaglandin F2a was only partially successful, regular contractions being established, but by 18 hours the active phase had not ensued. Thereafter intravenous BRITISH MEDICAL JOURNAL 22 APRIL 1972 Syntocinon was administered and spontaneous delivery occurred 100 minutes later. The remaining case (No. 20) was a failure and the only response to six doses of F2ta was distressing diarrhoea. Syntocinon in escalating dosage was then begun, resulting in spontaneous delivery six hours later. Maternal.-Mild gastrointestinal disturbance was noted in 9 of the 14 patients treated. This took the form of nausea with occasional vomiting or loose bowel motions. Only one patient (Case 20) was seriously inconvenienced. The usual time of onset of these symptoms was after three to five doses of prostaglandin F,a. There were no other side effects. Blood pressure and heart rate remained unaffected. In 11 of the 14 patients pretreatment and posttreatment blood chemistry, haematology, urine analysis, and electrolytes were evaluated as detailed for prostaglandin E2.
In no case was there significant alteration. There was no abnormal postpartum blood loss and no evidence of uterine hypertonicity during labour.
Fetal.-Observations on the fetal well-being were conducted throughout labour (Table III) . Only in Case 13, described above, was there fetal bradycardia, and the Apgar score at five minutes was 2. In the remaining cases the Apgar scores at five minutes were 10 (9 cases), 9 (2 cases), and 8 (2 cases).
Discussion
To the best of our knowledge there have been only two publications describing the clinical use of oral prostaglandins in the induction of labour. In the first of these Karim (1971) explored the effect of these drugs in a small pilot series of six cases, and in the second paper Karim and Sharma (1971) We do not feel that it is justifiable to persist with any single method of induction for more than six to eight hours, and if labour has not been established within that tine then alternative methods of induction should be sought. However, with further experience of these drugs it is probable that more effective dose schedules will be evolved without loss of safety to mother or infant. Neither drug seemed to have an adverse effect on mother or infant, but with F,x vomiting and diarrhoea occurred in most cases and this might prove to be a limiting factor in the number of doses administered.
It was also noted that the small number of patients who failed to respond to prostaglandin and were subsequently treated with intravenous infusion of Syntocinon proceeded rapidly to delivery. This supports the theory, at present under investigation, that there may be a synergistic action between these drugs.
In conclusion, there is no doubt that prostaglandins E2 and F,a, given by mouth, are often effective in inducing labour. Extensive trials are now in progress and it remains to be seen what role they will ultimately assume in the search for the ideal induction agent, which must be safe, effective, and convenient to use.
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